Table 2 Distribution of metastatic sites in relation to histological and immunohistochemical subtypes in a cohort of 62 patients
HYSTOLOGY | IHC | METASTATIC SITESa | TOTAL | ||||
|---|---|---|---|---|---|---|---|
Lung | Liver | Bone | Brain | EOM | |||
DUCTAL | LUMINAL A | 2 | 1 | 6 | 0 | 0 | 9 |
LUMINAL B HER2 - | 3 | 3 | 9 | 0 | 1 | 16 | |
LUMINAL B HER2 + | 3 | 3 | 3 | 1 | 0 | 10 | |
NO LUMINAL HER2 + | 3 | 2 | 1 | 2 | 0 | 8 | |
TRIPLE NEGATIVE | 5 | 1 | 4 | 0 | 0 | 10 | |
LOBULAR | LUMINAL A | 1 | 1 | 3 | 0 | 0 | 5 |
LUMINAL B HER2 - | 0 | 0 | 2 | 0 | 0 | 2 | |
LUMINAL B HER2 + | 0 | 0 | 1 | 0 | 0 | 1 | |
NO LUMINAL HER2 + | 0 | 0 | 0 | 0 | 0 | 0 | |
TRIPLE NEGATIVE | 0 | 0 | 1 | 0 | 0 | 1 | |
TOTAL | Â | 17 | 11 | 30 | 3 | 1 | 62 |